Ask AI
ProCE Banner Activity

Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression

Podcast Episodes

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal ART regimen for them. Stream this podcast to listen as Dima Dandachi, MD, MPH, FIDSA, FACP, and Chloe Orkin, MBChB, FRCP, MD, discuss key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen.

Released: November 21, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, nurses and other healthcare professionals who provide care for people living with HIV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Proactively identify people living with virologically suppressed HIV who may benefit from switching to a different ART regimen

  • Accurately appraise the benefits and risks associated with switching a suppressive ART regimen, including consideration related to efficacy, tolerability, convenience, and quality of life

Faculty Disclosure

Primary Author

Dima Dandachi, MD, MPH, FIDSA, FACP: consultant/advisor/speaker: Gilead, ViiV; researcher: Gilead, ViiV.

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, Merck Sharp & Dohme, ViiV.